CNS Pharmaceuticals, Inc.
General ticker "CNSP" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $108.6M (TTM average)
CNS Pharmaceuticals, Inc. does not follow the US Stock Market performance with the rate: -13.4%.
Estimated limits based on current volatility of 3.4%: low 6.30$, high 6.74$
Factors to consider:
- Total employees count: 3 as of 2019
- Top business risk factors: Insufficient funding, Going concern, Regulatory and compliance, Market competition, Labor/talent shortage/retention
- Current price 95.4% below estimated low
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [2084.52$, 36181.26$]
- 2024-12-30 to 2025-12-30 estimated range: [141.34$, 3147.12$]
Financial Metrics affecting the CNSP estimates:
- Negative: with PPE of -0.2 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -0.01 <= 0.33
- Negative: Shareholder equity ratio, % of -260.58 <= 18.93
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Negative: negative Industry operating income (median)
- Negative: Industry earnings per price (median), % of -22.08 <= 0
- Negative: -0.75 < Inventory ratio change, % of 0
Short-term CNSP quotes
Long-term CNSP plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $14.49MM | $15.27MM | $18.87MM |
| Operating Income | $-14.49MM | $-15.27MM | $-18.87MM |
| Non-Operating Income | $-0.01MM | $-0.01MM | $0.01MM |
| Interest Expense | $0.01MM | $0.01MM | $0.01MM |
| R&D Expense | $9.81MM | $9.30MM | $14.10MM |
| Income(Loss) | $-14.50MM | $-15.27MM | $-18.85MM |
| Profit(Loss)* | $-14.50MM | $-15.27MM | $-18.85MM |
| Stockholders Equity | $6.16MM | $8.13MM | $-4.43MM |
| Assets | $8.76MM | $13.05MM | $1.70MM |
| Operating Cash Flow | $-13.54MM | $-10.56MM | $-14.14MM |
| Capital expenditure | $0.01MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $-0.01MM | $-0.00MM | $-0.00MM |
| Financing Cash Flow | $4.51MM | $15.61MM | $4.64MM |
| Earnings Per Share** | $-10.27 | $-6.76 | $-3.03 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.